NOD2/RIG-I Activating Inarigivir Adjuvant Enhances the Efficacy of BCG Vaccine Against Tuberculosis in Mice

Tuberculosis (TB) caused by Mycobacterium tuberculosis (MTB) kills about 1.5 million people each year and the widely used Bacille Calmette-Guérin (BCG) vaccine provides a partial protection against TB in children and adults. Because BCG vaccine evades lysosomal fusion in antigen presenting cells (AP...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Arshad, Singh, Vipul K., Mishra, Abhishek, Soudani, Emily, Bakhru, Pearl, Singh, Christopher R., Zhang, Dekai, Canaday, David H., Sheri, Anjaneyulu, Padmanabhan, Seetharamaiyer, Challa, Sreerupa, Iyer, Radhakrishnan P., Jagannath, Chinnaswamy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751440/
https://www.ncbi.nlm.nih.gov/pubmed/33365029
http://dx.doi.org/10.3389/fimmu.2020.592333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751440/
https://www.ncbi.nlm.nih.gov/pubmed/33365029
http://dx.doi.org/10.3389/fimmu.2020.592333

Ejemplares similares